Chronic Thromboembolic Pulmonary Hypertension

Cardiovascular
0
Pipeline Programs
1
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Bayer
BayerLEVERKUSEN, Germany
2 programs
Balloon Pulmonary AngioplastyN/A2 trials
On-screen computerized decision support alertN/A1 trial
Active Trials
NCT03409588Completed10Est. Jan 2026
NCT02634203Completed105Est. Jan 2020
NCT03729544Completed400Est. Dec 2025

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
BayerBalloon Pulmonary Angioplasty
BayerOn-screen computerized decision support alert
BayerBalloon Pulmonary Angioplasty

Clinical Trials (3)

Total enrollment: 515 patients across 3 trials

NCT03409588BayerBalloon Pulmonary Angioplasty

Treatment of Exercise-Induced Pulmonary Vascular Dysfunction After Pulmonary Thromboendarterectomy or Balloon Pulmonary Angioplasty

Start: Jun 2018Est. completion: Jan 202610 patients
Phase 2Completed
NCT03729544BayerOn-screen computerized decision support alert

Computerized Decision Support to Increase Detection of Chronic Thromboembolic Pulmonary Hypertension in Patients With Prior Pulmonary Embolism

Start: Mar 2019Est. completion: Dec 2025400 patients
N/ACompleted
NCT02634203BayerBalloon Pulmonary Angioplasty

Riociguat Versus Balloon Pulmonary Angioplasty in Non-operable Chronic thromboEmbolic Pulmonary Hypertension

Start: Jan 2016Est. completion: Jan 2020105 patients
N/ACompleted

Related Jobs in Cardiovascular

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space